PlainRecalls
FDA Drug Moderate Class II Ongoing

darby dental supply, MEPIVACAINE, Mepivacaine HCI 3% (30mg/mL) Injection, [Mepivacaine HCI Injection, USP], packaged in a carton containing 50 single-dose Cartridges, 1.7 mL each, Rx only, Manufactured by Novocol Pharmaceutical of Canada, Inc., NDC 66467-9760-5.

Reported: December 24, 2025 Initiated: October 31, 2025 #D-0231-2026

Product Description

darby dental supply, MEPIVACAINE, Mepivacaine HCI 3% (30mg/mL) Injection, [Mepivacaine HCI Injection, USP], packaged in a carton containing 50 single-dose Cartridges, 1.7 mL each, Rx only, Manufactured by Novocol Pharmaceutical of Canada, Inc., NDC 66467-9760-5.

Reason for Recall

Defective container: cracked/broken cartridges

Details

Units Affected
5,520 Cartons
Distribution
U.S.A. Nationwide
Location
Cambridge

Frequently Asked Questions

What product was recalled?
darby dental supply, MEPIVACAINE, Mepivacaine HCI 3% (30mg/mL) Injection, [Mepivacaine HCI Injection, USP], packaged in a carton containing 50 single-dose Cartridges, 1.7 mL each, Rx only, Manufactured by Novocol Pharmaceutical of Canada, Inc., NDC 66467-9760-5.. Recalled by Novocol Pharmaceutical of Canada, Inc.. Units affected: 5,520 Cartons.
Why was this product recalled?
Defective container: cracked/broken cartridges
Which agency issued this recall?
This recall was issued by the FDA Drug on December 24, 2025. Severity: Moderate. Recall number: D-0231-2026.